Vectormune FP ILT

País: Unión Europea

Idioma: neerlandés

Fuente: EMA (European Medicines Agency)

Ingredientes activos:

recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live

Disponible desde:

CEVA-Phylaxia Co. Ltd.

Designación común internacional (DCI):

Fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant)

Grupo terapéutico:

Kip

indicaciones terapéuticas:

For active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Estado de Autorización:

Erkende

Fecha de autorización:

2020-12-09

Información para el usuario

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Actuele informatie over dit geneesmiddel voor diergeneeskundig gebruik
is beschikbaar op de website
over diergeneesmiddelen.

Ficha técnica

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Actuele informatie over dit geneesmiddel voor diergeneeskundig gebruik
is beschikbaar op de website
over diergeneesmiddelen.